A Predictive Model for Severe COVID-19 in the Medicare Population: A Tool for Prioritizing Primary and Booster COVID-19 Vaccination

被引:8
|
作者
Experton, Bettina [1 ]
Tetteh, Hassan A. [2 ]
Lurie, Nicole [3 ,4 ]
Walker, Peter [5 ]
Elena, Adrien [1 ]
Hein, Christopher S. [1 ]
Schwendiman, Blake [1 ]
Vincent, Justin L. [6 ]
Burrow, Christopher R. [1 ]
机构
[1] Humetrix Inc, Del Mar, CA 90214 USA
[2] Dept Def Joint Artificial Intelligence Ctr JAIC, Warfighter Hlth Mission Team, Arlington, VA 22202 USA
[3] Coalit Epidem Preparedness Innovat CEPI, Washington, DC 20006 USA
[4] Harvard Med Sch, Dept Med, Boston, MA 02115 USA
[5] US Navy, Washington, DC 20376 USA
[6] Amazon Web Serv Inc, Seattle, WA 98109 USA
来源
BIOLOGY-BASEL | 2021年 / 10卷 / 11期
关键词
COVID-19 vaccine prioritization; COVID-19 booster vaccine; severe COVID-19 disease; risk for severe COVID-19 infection; COVID-19 vaccine booster prioritization; Medicare population; severe COVID-19 risk model;
D O I
10.3390/biology10111185
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple SummaryWhether it is for COVID-19 primary vaccination or the administration of booster vaccines, prioritization criteria need to be established to optimize COVID-19 vaccination programs accounting for both clinical and social vulnerability risks for severe COVID-19 disease. We developed a dual socio-clinical risk model for severe COVID-19 disease in the Medicare population, which is comprised mostly of individuals aged 65 and over. Our model generated risk levels correlated with regionalized COVID-19 case hospitalization rates and mapped them at the county and zip code levels. The model and map can be used by health jurisdictions to reach out to unvaccinated individuals. Our model approach can also be applied to identify Medicare beneficiaries who were in early vaccination groups to be vaccinated to identify those who might maximally benefit from an additional dose of COVID-19 vaccine if and when vaccine immunity wanes.Recommendations for prioritizing COVID-19 vaccination have focused on the elderly at higher risk for severe disease. Existing models for identifying higher-risk individuals lack the needed integration of socio-demographic and clinical risk factors. Using multivariate logistic regression and random forest modeling, we developed a predictive model of severe COVID-19 using clinical data from Medicare claims for 16 million Medicare beneficiaries and socio-economic data from the CDC Social Vulnerability Index. Predicted individual probabilities of COVID-19 hospitalization were then calculated for population risk stratification and vaccine prioritization and mapping. The leading COVID-19 hospitalization risk factors were non-white ethnicity, end-stage renal disease, advanced age, prior hospitalization, leukemia, morbid obesity, chronic kidney disease, lung cancer, chronic liver disease, pulmonary fibrosis or pulmonary hypertension, and chemotherapy. However, previously reported risk factors such as chronic obstructive pulmonary disease and diabetes conferred modest hospitalization risk. Among all social vulnerability factors, residence in a low-income zip code was the only risk factor independently predicting hospitalization. This multifactor risk model and its population risk dashboard can be used to optimize COVID-19 vaccine allocation in the higher-risk Medicare population.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Pediatric vaccination against COVID-19 and despite COVID-19
    Martinon-Torres, Federico
    [J]. ANALES DE PEDIATRIA, 2022, 96 (01): : 4 - 7
  • [42] Subacute Thyroiditis Following COVID-19 and COVID-19 Vaccination
    Duskin-Bitan, Hadar
    Robenshtok, Eyal
    Peretz, Alon
    Beckenstein, Tanya
    Tsur, Nir
    Netzer, Doron
    Cohen, Arnon D.
    Saliba, Walid
    Shimon, Ilan
    Gorshtein, Alexander
    [J]. ENDOCRINE PRACTICE, 2024, 30 (08) : 731 - 736
  • [43] Covid-19 vaccination coverage by birth country and underlying risk for severe Covid-19 disease
    Delalic, L.
    Gjefsen, H. M.
    Hussaini, L.
    Gleditsch, R. N.
    Winje, B. A.
    Godoy, A. A.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2023, 33
  • [44] Prioritizing incarcerated populations for COVID-19 vaccination and vaccine trials
    Kronfli, Nadine
    Akiyama, Matthew J.
    [J]. ECLINICALMEDICINE, 2021, 31
  • [45] A predictive model for COVID-19 spreading
    Xie, Jiarong
    Sun, Jiachen
    Liu, Xun
    Sun, Xiaoqiang
    He, Qun
    Hu, Yanqing
    [J]. CHINESE SCIENCE BULLETIN-CHINESE, 2020, 65 (22): : 2348 - 2355
  • [46] A predictive model to explore risk factors for severe COVID-19
    Qian, Fen-Hong
    Cao, Yu
    Liu, Yu-Xue
    Huang, Jing
    Zhu, Rong-Hao
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [47] A Predictive Model for the Evolution of COVID-19
    Rajneesh Bhardwaj
    [J]. Transactions of the Indian National Academy of Engineering, 2020, 5 (2) : 133 - 140
  • [48] Predictive factors of progression to severe COVID-19
    Zhou, Yi-Hong
    Li, Huan
    Qin, Yuan-Yuan
    Yan, Xiao-Feng
    Lu, Yan-Qiu
    Liu, Hong-Lan
    Ye, Si-Kuan
    Wan, Yan
    Zhang, Lu
    Harypursat, Vijay
    Chen, Yaokai
    [J]. OPEN MEDICINE, 2020, 15 (01): : 805 - 814
  • [49] Rates of SARS-CoV-2 infection or severe COVID-19 in persons with diabetes after initial and booster COVID-19 vaccination in the Netherlands
    van den Berg, J. M.
    Blom, M. T.
    Swart, K. M. A.
    Overbeek, J. A.
    Remmelzwaal, S.
    Herings, R. M. C.
    Elders, P. J. M.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S175 - S176
  • [50] A model and predictions for COVID-19 considering population behavior and vaccination
    Usherwood, Thomas
    LaJoie, Zachary
    Srivastava, Vikas
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)